Fundamenta Therapeutics, Ltd.
Fundamenta Therapeutics, Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. | Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | Recruiting | Early phase 1 | 2026-06-17 | NCT07074496 |